American drug giant Pfizer has officially opened a Manufacturing Technology Development Centre here to develop new high-tech manufacturing technologies.
The firm declined to reveal how much it invested but said the centre on Jurong Island will bump up its staff strength here by hiring chemical engineers, chemists and analysts. The centre will collaborate with the Agency for Science, Technology and Research's Institute of Chemical and Engineering Sciences, universities and other research institutes.
It will provide engineering and chemistry solutions to support operations at Pfizer's Tuas manufacturing facility and throughout its global network.
The launch "demonstrates our continued focus on innovating to bring therapies that significantly improve patients' lives as well as manufacturing excellence", said Mr George Routhier, the managing director and site leader of Pfizer Asia Pacific.
The Economic Development Board's director of biomedical sciences, Ms Ho Weng Si, noted that the move is "testament to Singapore's capabilities as a global pharmaceutical hub, and is aligned with our continued focus on positioning Singapore as a choice location for companies to develop manufacturing technologies that will drive the production of current and future pipeline products".
Pfizer is best known for drugs such as Lipitor, used to lower blood cholesterol, and Viagra, for erectile dysfunction. The company has had a presence in Singapore since 1964, when it started out with 10 employees. It now has more than 600 staff here - about 500 at its Tuas manufacturing site and 100 in its corporate office.